
Dulaglutide
CAS: 923950-08-7
Dulaglutide is a research peptide in the glp-1 / weight management category. Dulaglutide is a GLP-1 receptor agonist that consists of a modified GLP-1 analog fused to a human IgG4 Fc domain. MiPeptidos offers Dulaglutide in 2 sizes with 99.1% verified purity and full analytical documentation.
How Dulaglutide Works
Dulaglutide is a GLP-1 receptor agonist that consists of a modified GLP-1 analog fused to a human IgG4 Fc domain. The Fc fusion dramatically extends the half-life by reducing renal clearance and engaging FcRn-mediated recycling. It stimulates insulin secretion in a glucose-dependent manner, suppresses glucagon, delays gastric emptying, and reduces appetite through central nervous system signaling.
Research Applications
Pricing
| Size | Per Vial | 10-Pack |
|---|---|---|
5mg | $68.95 | $502.95 |
10mgBest Value | $120.95 | $882.95 |
Prices shown per vial from 10-pack. Volume discounts available for 50+ vials — contact us.
HPLC Purity Analysis
Certificate of Analysis
This COA is a representative sample. A batch-specific Certificate of Analysis with full HPLC chromatograms and mass spectrometry data is included with every MiPeptidos order.
Reconstitution Calculator
Inject bacteriostatic water slowly along the vial wall. Gently swirl until dissolved — never shake. Store reconstituted solution at 2-8°C and use within 30 days.
Download Product Brochure
Get our detailed Dulaglutide product brochure with specifications, research applications, HPLC analysis data, and reconstitution guide. Available in English and Spanish.
Customer Reviews
Frequently Asked Questions
Specifications
Sequence
Fusion protein consisting of a GLP-1(7-37) analog covalently linked via a peptide linker to the Fc fragment of human IgG4; exists as two identical disulfide-linked chains
Research Use Only. This product is intended for laboratory research purposes only. Not for human consumption. Handle with appropriate safety precautions.
Related Peptides

Semaglutide
A glucagon-like peptide-1 (GLP-1) receptor agonist originally developed for glycemic control. Widely studied for its role in appetite regulation and metabolic research.

Tirzepatide
A dual GIP/GLP-1 receptor agonist studied for its effects on glucose metabolism and body weight regulation. One of the most researched peptides in the incretin class.

Retatrutide
A triple agonist targeting GIP, GLP-1, and glucagon receptors. Investigated in preclinical and clinical research for its multi-pathway approach to metabolic regulation.

Liraglutide
A GLP-1 receptor agonist with an extended half-life due to fatty acid acylation. Extensively studied for glucose homeostasis and appetite signaling research.